Redergin en es it fr

Redergin Brand names, Redergin Analogs

Redergin Brand Names Mixture

  • No information avaliable

Redergin Chemical_Formula


Redergin RX_link

No information avaliable

Redergin fda sheet

Redergin msds (material safety sheet)

Redergin Synthesis Reference

No information avaliable

Redergin Molecular Weight

591.741 g/mol

Redergin Melting Point

No information avaliable

Redergin H2O Solubility

No information avaliable

Redergin State


Redergin LogP


Redergin Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Redergin Indication

For use as an adjunct therapy for patients with dementia

Redergin Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Redergin Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Redergin side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Redergin Patient Information

No information avaliable

Redergin Organisms Affected

Humans and other mammals